نتائج البحث

Association between CYP2D6 phenotype and recurrence of Plasmodium vivax infection in south Korean patients.

• Authors : Choi, Sungim¹ (AUTHOR); Choi, Heun² (AUTHOR); Park, Seong Yeon¹ (AUTHOR)

• Source: Malaria Journal. 10/10/2022, Vol. 21 Issue 1, p1-8. 8p.

تفاصيل العنوان

Prediction of the CYP2D6 enzymatic activity based on investigating of the CYP2D6 genotypes around the vivax malaria patients in Yunnan Province, China.

• Authors : Dong, Ying¹ (AUTHOR) ; Huang, Herong² (AUTHOR); Deng, Yan¹ (AUTHOR)

• Source: Malaria Journal. 11/25/2021, Vol. 20 Issue 1, p1-10. 10p.

تفاصيل العنوان

A single low dose of primaquine is safe and sufficient to reduce transmission of Plasmodium falciparum gametocytes regardless of cytochrome P450 2D6 enzyme activity in Bagamoyo district, Tanzania.

• Authors : Mwaiswelo RO; Department of Research and Training, Tropical Pesticides Research Institute, Arusha, Tanzania. .; Department of Microbiology, Immunology and Parasitology, Hubert Kairuki Memorial University, Dar es Salaam, Tanzania. .

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Cytochrome P-450 CYP2D6*/Cytochrome P-450 CYP2D6*/Cytochrome P-450 CYP2D6*/genetics; Artemether

• Source: Malaria journal [Malar J] 2022 Mar 12; Vol. 21 (1), pp. 84. Date of Electronic Publication: 2022 Mar 12.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

تفاصيل العنوان

The association of CYP2D6 gene polymorphisms in the full-length coding region with higher recurrence rate of vivax malaria in Yunnan Province, China.

• Authors : Huang, Herong¹ (AUTHOR); Dong, Ying² (AUTHOR) ; Xu, Yanchun² (AUTHOR)

• Source: Malaria Journal. 3/20/2021, Vol. 20 Issue 1, p1-10. 10p.

تفاصيل العنوان

Cytochrome P450 2D6 profiles and their relationship with outcomes of primaquine anti-relapse therapy in Australian Defence Force personnel deployed to Papua New Guinea and East Timor.

• Authors : Chen N; Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, QLD, Australia.; Dowd S

Subjects: Antimalarials/Antimalarials/Antimalarials/*therapeutic use ; Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/*genetics ; Malaria, Vivax/Malaria, Vivax/Malaria, Vivax/*drug therapy

• Source: Malaria journal [Malar J] 2019 Apr 18; Vol. 18 (1), pp. 140. Date of Electronic Publication: 2019 Apr 18.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

تفاصيل العنوان

Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study.

• Authors : Puaprasert, Kanokpich¹; Chu, Cindy^2,3; Saralamba, Naowarat¹

• Source: Malaria Journal. 11/15/2018, Vol. 17 Issue 1, p1-12. 12p. 2 Diagrams, 4 Charts, 1 Map.

تفاصيل العنوان

CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study.

• Authors : Brasil, Larissa W.^1,2; Rodrigues-Soares, Fernanda²; Santoro, Ana B.³

• Source: Malaria Journal. 2/1/2018, Vol. 17, p1-N.PAG. 6p. 4 Charts, 1 Graph.

تفاصيل العنوان

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.

• Authors : Baird JK; Eijkman-Oxford Clinical Research Unit, Jalan Diponegoro No.69, Central Jakarta, 10430, Indonesia.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford, OX3 7FZ, UK.

Subjects: Polymorphism, Single Nucleotide*; Antimalarials/Antimalarials/Antimalarials/*therapeutic use ; Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/*genetics

• Source: Malaria journal [Malar J] 2018 Jan 22; Vol. 17 (1), pp. 42. Date of Electronic Publication: 2018 Jan 22.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

تفاصيل العنوان

Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei.

• Authors : Milner EE; Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA. .; Berman J

Subjects: Aminoquinolines/Aminoquinolines/Aminoquinolines/*pharmacology ; Antimalarials/Antimalarials/Antimalarials/*pharmacology ; Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/*metabolism

• Source: Malaria journal [Malar J] 2016 Dec 07; Vol. 15 (1), pp. 588. Date of Electronic Publication: 2016 Dec 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

تفاصيل العنوان

Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds.

• Authors : Marcsisin SR; Division of Experimental Therapeutics, Military Malaria Research Program, Walter Reed Army Institute of Research, 503 Robert Grant Ave, Silver Spring, MD 20910, USA. .; Sousa JC

Subjects: Aminoquinolines/Aminoquinolines/Aminoquinolines/*metabolism ; Antimalarials/Antimalarials/Antimalarials/*metabolism ; Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/*metabolism

• Source: Malaria journal [Malar J] 2014 Jan 03; Vol. 13, pp. 2. Date of Electronic Publication: 2014 Jan 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

تفاصيل العنوان